Attached files
EXHIBIT 32.1
CERTIFICATION REQUIRED BY
SECTION 1350 OF TITLE 18 OF THE UNITED STATES CODE
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of
the undersigned hereby certifies in his capacity as the specified
officer of Innovus Pharmaceuticals, Inc. (the
“Company”), that, to the best of his knowledge, the
Quarterly Report of the Company on Form 10-Q for the fiscal quarter
ended September 30, 2016 fully complies with the requirements of
Section 13(a) or 15(d), as applicable, of the Securities Exchange
Act of 1934, and that the information contained in such report
fairly presents, in all material respects, the financial condition
and results of operations of the Company as of the dates and for
the periods presented in the financial statements included in such
report.
Date:
November 14, 2016
|
|
|
|
/s/ Bassam
Damaj
|
|
Bassam
Damaj, Ph.D, President and Chief Executive Officer
|
|
(Principal
Executive Officer)
|
|
Date:
November 14, 2016
|
|
|
|
/s/ Robert E.
Hoffman
|
|
Robert
E. Hoffman, Executive Vice President and Chief Financial
Officer
|
|
(Principal
Financial Officer)
|
|
This certification accompanies this Report on Form 10-Q
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall
not be deemed filed by the Company for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the
“Exchange Act”). Such certification will not be deemed
to be incorporated by reference into any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except to
the extent that the Company specifically incorporates it by
reference.